Welcome to LookChem.com Sign In|Join Free

CAS

  • or

147523-65-7

Post Buying Request

147523-65-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

147523-65-7 Usage

Uses

LY 288513 is a CCK-B antagonist, which blocks the effects of nicotine withdrawal on auditory startle.

Biological Activity

Selective CCK 2 receptor antagonist (IC 50 values are 16 and > 30,000 nM for CCK 2 and CCK 1 respectively). Displays anxiolytic and antipsychotic properties in vivo .

Check Digit Verification of cas no

The CAS Registry Mumber 147523-65-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,5,2 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 147523-65:
(8*1)+(7*4)+(6*7)+(5*5)+(4*2)+(3*3)+(2*6)+(1*5)=137
137 % 10 = 7
So 147523-65-7 is a valid CAS Registry Number.
InChI:InChI=1/C22H18BrN3O2/c23-17-11-13-18(14-12-17)24-22(28)26-20(16-9-5-2-6-10-16)19(21(27)25-26)15-7-3-1-4-8-15/h1-14,19-20H,(H,24,28)(H,25,27)/t19-,20-/m0/s1

147523-65-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name LY 288513,(4S,5R)-N-(4-Bromophenyl)-3-oxo-4,5-diphenyl-1-pyrazolidinecarboxamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:147523-65-7 SDS

147523-65-7Upstream product

147523-65-7Downstream Products

147523-65-7Relevant articles and documents

PYRAZOLIDIN-3-ONE DERIVATIVES

-

, (2008/06/13)

The present invention provides an enantiomerically selective process and intermediates for preparing certain 4,5-disubstituted pyrazolidinones and intermediates which are useful for treating diseases of the central nervous system.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 147523-65-7